HomepageAFX • ETR
add
Carl Zeiss Meditec
Vorige slotkoers
€ 27,00
Dag-range
€ 26,80 - € 27,36
Jaar-range
€ 25,20 - € 71,65
Beurswaarde
2,44Â mld. EUR
Gem. volume
474,06K
Koers/winst
19,78
Dividendrendement
2,02%
Primaire beurs
ETR
Marktnieuws
Yahoo Finance
12 uur geleden
Apple Decouples From Nasdaq, Offering Alternative to AI-Fueled Volatility
0,18%
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (EUR) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 467,00Â mln. | -4,79% |
Bedrijfskosten | 227,50Â mln. | 1,52% |
Netto inkomsten | -4,90Â mln. | -131,21% |
Netto winstmarge | -1,05 | -132,81% |
Winst per aandeel | 0,03 | -91,67% |
EBITDA | 12,31Â mln. | -67,09% |
Effectief belastingtarief | -3,64% | — |
Balans
Totale activa
Totale passiva
| (EUR) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 27,27Â mln. | 34,42% |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 2,13 mld. | — |
Uitstaande aandelen | 81,67 mln. | — |
Koers-boekwaardeverhouding | 1,12 | — |
Rendement op activa | — | — |
Rendement op kapitaal | -0,03% | — |
Kasstroom
Nettomutatie in liquide middelen
| (EUR) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -4,90Â mln. | -131,21% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications.
Founded in 2002, ZEISS Medical Technology employs thousands of professionals worldwide and maintains a presence in dozens of countries around the world.
In 2025, the parent company, Carl Zeiss Group, marked 100 years in the United States.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
CEO
Opgericht
2002
Hoofdvestiging
Werknemers
5.784
